112 related articles for article (PubMed ID: 6305791)
1. Molecular dissection of the bovine leukemia virus envelope glycoprotein (BLV gp51) by a monoclonal antibody study.
Bruck C; Portetelle D; Zavada J; Burny A
Haematol Blood Transfus; 1983; 28():222-6. PubMed ID: 6305791
[No Abstract] [Full Text] [Related]
2. Monoclonal antibodies define eight independent antigenic regions on the bovine leukemia virus (BLV) envelope glycoprotein gp51.
Bruck C; Mathot S; Portetelle D; Berte C; Franssen JD; Herion P; Burny A
Virology; 1982 Oct; 122(2):342-52. PubMed ID: 6183819
[No Abstract] [Full Text] [Related]
3. Bovine monoclonal antibody to bovine leukemia virus glycoprotein GP51 from bovine-murine hybridoma.
Tanaka M; Okabe T; Sasaki N
Nihon Juigaku Zasshi; 1988 Oct; 50(5):1136-8. PubMed ID: 2848966
[No Abstract] [Full Text] [Related]
4. Epitopes of bovine leukemia virus glycoprotein gp51 recognized by sera of infected cattle and sheep.
Bruck C; Portetelle D; Mammerickx M; Mathot S; Burny A
Leuk Res; 1984; 8(3):315-21. PubMed ID: 6205222
[TBL] [Abstract][Full Text] [Related]
5. Production of monoclonal antibody to bovine leukemia virus glycoprotein gp51 by in vitro immunization.
Sasaki O; Tanaka M; Okabe T; Imanishi J
Microbiol Immunol; 1990; 34(4):401-5. PubMed ID: 2163485
[TBL] [Abstract][Full Text] [Related]
6. Use of two monoclonal antibodies in an ELISA test for the detection of antibodies to bovine leukaemia virus envelope protein gp51.
Portetelle D; Mammerickx M; Burny A
J Virol Methods; 1989 Feb; 23(2):211-22. PubMed ID: 2542354
[TBL] [Abstract][Full Text] [Related]
7. Use of monoclonal antibody in an ELISA test for the detection of antibodies to bovine leukaemia virus.
Portetelle D; Bruck C; Mammerickx M; Burny A
J Virol Methods; 1983 Jan; 6(1):19-29. PubMed ID: 6300156
[TBL] [Abstract][Full Text] [Related]
8. Topographical analysis by monoclonal antibodies of BLV-gp51 epitopes involved in viral functions.
Bruck C; Portetelle D; Burny A; Zavada J
Virology; 1982 Oct; 122(2):353-62. PubMed ID: 6183820
[No Abstract] [Full Text] [Related]
9. Natural antibodies to BLV gp51 are reactive against the carbohydrate moiety of the glycoprotein.
Portetelle D; Bruck C; Mammerickx M; Burny A
Haematol Blood Transfus; 1981; 26():498-501. PubMed ID: 6172322
[No Abstract] [Full Text] [Related]
10. [Use of a monoclonal antibody against envelope protein gp51 of bovine leukemia virus in a test for the diagnosis of enzootic bovine leukosis].
Siakkou H; Platzer C; Beier D; Olechnowitz AF; Rosenthal S
Arch Exp Veterinarmed; 1990; 44(2):223-31. PubMed ID: 2167049
[TBL] [Abstract][Full Text] [Related]
11. Biologically active epitopes of bovine leukemia virus glycoprotein gp51: their dependence on protein glycosylation and genetic variability.
Bruck C; Rensonnet N; Portetelle D; Cleuter Y; Mammerickx M; Burny A; Mamoun R; Guillemain B; van der Maaten MJ; Ghysdael J
Virology; 1984 Jul; 136(1):20-31. PubMed ID: 6204449
[TBL] [Abstract][Full Text] [Related]
12. Immunohistological demonstration of virus and tumor associated antigens in tissues experimental and spontaneous bovine leukemia virus (BLV) infection.
Reinacher M; Thurmond MC; Onuma M; Portetelle D; Picanso J; Theilen GH
Vet Immunol Immunopathol; 1989 Oct; 22(3):223-31. PubMed ID: 2560854
[TBL] [Abstract][Full Text] [Related]
13. Antigenic variants of bovine leukemia virus (BLV) are defined by amino acid substitutions in the NH2 part of the envelope glycoprotein gp51.
Portetelle D; Couez D; Bruck C; Kettmann R; Mammerickx M; Van der Maaten M; Brasseur R; Burny A
Virology; 1989 Mar; 169(1):27-33. PubMed ID: 2466370
[TBL] [Abstract][Full Text] [Related]
14. Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.
Portetelle D; Dandoy C; Burny A; Zavada J; Siakkou H; Gras-Masse H; Drobecq H; Tartar A
Virology; 1989 Mar; 169(1):34-41. PubMed ID: 2466371
[TBL] [Abstract][Full Text] [Related]
15. In animals infected by bovine leukemia virus (BLV) antibodies to envelope glycoprotein gp51 are directed against the carbohydrate moiety.
Portetelle D; Bruck C; Mammerickx M; Burny A
Virology; 1980 Aug; 105(1):223-33. PubMed ID: 6158161
[No Abstract] [Full Text] [Related]
16. Immunoaffinity purification of two major proteins of bovine leukemia virus (gp51 and p24) and their use for discrimination between vaccinated and infected animals.
Merza M; Sundquist B; Söber J; Morein B
J Virol Methods; 1991 Aug; 33(3):345-53. PubMed ID: 1723735
[TBL] [Abstract][Full Text] [Related]
17. BLV receptor activity in plasma membranes from tumorous lymph nodes of BLV-infected cows.
Ristau E; Roessler H; Burkardt H; Scholz D; Rosenthal S
Acta Virol; 1986 Nov; 30(6):449-56. PubMed ID: 2881463
[TBL] [Abstract][Full Text] [Related]
18. Elicitation of bovine antibody to BLV-gp51 by BLV-vaccination.
Maruyama K; Fukushima T; Mochizuki S; Abe H; Onuma M; Hasegawa A; Misawa M
Leukemia; 1988 Dec; 2(12 Suppl):216S-222S. PubMed ID: 2848999
[TBL] [Abstract][Full Text] [Related]
19. Identification of bovine leukemia virus (BLV) infected cattle by complex-trapping-blocking (CTB) ELISA employing monoclonal antibodies directed against BLV-p24.
de Boer GF; Boerrigter HM; Groen J; Osterhaus AD
Zentralbl Veterinarmed B; 1987 Dec; 34(10):717-28. PubMed ID: 2830742
[No Abstract] [Full Text] [Related]
20. Antigen capture assay for detection of bovine leukemia virus proteins by monoclonal antibodies.
Bán J; Altanerová V; Orlík O; Altaner C
Neoplasma; 1991; 38(6):625-31. PubMed ID: 1662780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
